Garth Lees-Rolfe

Chief Financial Officer, Inhibikase Therapeutics, Inc.

Companies

LUDWIG ENTERPRISES, INC.Board member Jun 26, 2025 to now¹
Inhibikase Therapeutics, Inc.Chief financial officer Apr 2, 2024 to Jan 22, 2025²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLUDWIG ENTERPRISES, INC., Board member
2
SEC EDGARInhibikase Therapeutics, Inc., Chief financial officer